
Erinne R. Dabkowski
Examiner (ID: 9598, Phone: (571)272-1829 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 857 |
| Issued Applications | 384 |
| Pending Applications | 153 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18056458
[patent_doc_number] => 20220387544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => NOVEL THERAPEUTIC USE
[patent_app_type] => utility
[patent_app_number] => 17/597940
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597940
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597940 | NOVEL THERAPEUTIC USE | Aug 8, 2019 | Abandoned |
Array
(
[id] => 17154912
[patent_doc_number] => 20210315963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/266897
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266897 | TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS | Aug 8, 2019 | Pending |
Array
(
[id] => 15147725
[patent_doc_number] => 20190352340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/534200
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16534200
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/534200 | Peptide compounds to regulate the complement system | Aug 6, 2019 | Issued |
Array
(
[id] => 16769740
[patent_doc_number] => 10980823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Performance food product
[patent_app_type] => utility
[patent_app_number] => 16/531349
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 4816
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531349
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/531349 | Performance food product | Aug 4, 2019 | Issued |
Array
(
[id] => 16915813
[patent_doc_number] => 20210188905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMBINING BETA-DIPEPTIDES AND AMINO ACIDS FOR OPTIMAL NUTRITIONAL SUPPLEMENTATION
[patent_app_type] => utility
[patent_app_number] => 17/263130
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263130 | COMBINING BETA-DIPEPTIDES AND AMINO ACIDS FOR OPTIMAL NUTRITIONAL SUPPLEMENTATION | Jul 30, 2019 | Abandoned |
Array
(
[id] => 15267459
[patent_doc_number] => 20190382463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => NON-STANDARD INSULIN ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 16/523266
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523266
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523266 | Non-standard insulin analogues | Jul 25, 2019 | Issued |
Array
(
[id] => 15345269
[patent_doc_number] => 20200010526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/519898
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16519898
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/519898 | NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF | Jul 22, 2019 | Abandoned |
Array
(
[id] => 19311570
[patent_doc_number] => 12037373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Multimeric and multivalent polymer comprising multimerization peptide domain
[patent_app_type] => utility
[patent_app_number] => 16/456204
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 5689
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16456204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/456204 | Multimeric and multivalent polymer comprising multimerization peptide domain | Jun 27, 2019 | Issued |
Array
(
[id] => 19717356
[patent_doc_number] => 12202879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => PD-L1 variants with enhanced binding affinity to PD-1
[patent_app_type] => utility
[patent_app_number] => 17/255629
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8079
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255629 | PD-L1 variants with enhanced binding affinity to PD-1 | Jun 26, 2019 | Issued |
Array
(
[id] => 15254149
[patent_doc_number] => 20190375808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => ANALOGUES OF VDAC1-DERlVED PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/451520
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16451520
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/451520 | Analogues of VDAC1-derived peptides | Jun 24, 2019 | Issued |
Array
(
[id] => 15020951
[patent_doc_number] => 20190321480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => COMPOSITIONS AND METHODS FOR TRANSPORT ACROSS THE BLOOD BRAIN BARRIER
[patent_app_type] => utility
[patent_app_number] => 16/450831
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16450831
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/450831 | Compositions and methods for transport across the blood brain barrier | Jun 23, 2019 | Issued |
Array
(
[id] => 16876872
[patent_doc_number] => 11026992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation
[patent_app_type] => utility
[patent_app_number] => 16/448960
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 40
[patent_no_of_words] => 11285
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448960
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448960 | Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation | Jun 20, 2019 | Issued |
Array
(
[id] => 16876872
[patent_doc_number] => 11026992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation
[patent_app_type] => utility
[patent_app_number] => 16/448960
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 40
[patent_no_of_words] => 11285
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448960
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448960 | Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation | Jun 20, 2019 | Issued |
Array
(
[id] => 16221311
[patent_doc_number] => 20200246427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING DAMAGE TO THE HEART
[patent_app_type] => utility
[patent_app_number] => 16/445086
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445086
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445086 | Methods and compositions for preventing and treating damage to the heart | Jun 17, 2019 | Issued |
Array
(
[id] => 14960377
[patent_doc_number] => 20190307666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => PEPTIDE COMPOSITION AND RESPECTIVE USES
[patent_app_type] => utility
[patent_app_number] => 16/439889
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16439889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/439889 | Peptide composition and respective uses | Jun 12, 2019 | Issued |
Array
(
[id] => 17034914
[patent_doc_number] => 20210251872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => FUSION PROTEIN BOUND TO CELL-PERMEABLE PEPTIDE, AND
COMPOSITION COMPRISING FUSION PROTEIN OR CELL-PERMEABLE
PEPTIDE AND EPITHELIAL CELL GROWTH FACTOR AS ACTIVE
INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 17/251454
[patent_app_country] => US
[patent_app_date] => 2019-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251454 | Fusion protein bound to cell-permeable peptide, and composition comprising fusion protein or cell-permeable peptide and epithelial cell growth factor as active ingredients | Jun 6, 2019 | Issued |
Array
(
[id] => 17243451
[patent_doc_number] => 20210363194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => FERRITIN NANOPARTICLE DISPLAYING AN HIV TRIMER
[patent_app_type] => utility
[patent_app_number] => 17/255408
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255408 | FERRITIN NANOPARTICLE DISPLAYING AN HIV TRIMER | Jun 4, 2019 | Pending |
Array
(
[id] => 17243451
[patent_doc_number] => 20210363194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => FERRITIN NANOPARTICLE DISPLAYING AN HIV TRIMER
[patent_app_type] => utility
[patent_app_number] => 17/255408
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255408 | FERRITIN NANOPARTICLE DISPLAYING AN HIV TRIMER | Jun 4, 2019 | Pending |
Array
(
[id] => 16013509
[patent_doc_number] => 20200181597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities
[patent_app_type] => utility
[patent_app_number] => 16/427593
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427593
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427593 | Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities | May 30, 2019 | Pending |
Array
(
[id] => 15290765
[patent_doc_number] => 20190388518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => Formulations for Nutritional Support in Subjects in Need Thereof
[patent_app_type] => utility
[patent_app_number] => 16/428589
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16428589
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/428589 | Formulations for Nutritional Support in Subjects in Need Thereof | May 30, 2019 | Abandoned |